secwatch.observer — SEC 8-K summary
======================================

Issuer:     Camp4 Therapeutics Corp (CAMP)
CIK:        0001736730
Form:       8-K
Filed at:   2026-06-12T20:10:37+00:00
Accession:  0001628280-26-042846
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CAMP4 stockholders approve 2024 Plan amendment; Board adopts 2026 Inducement Plan (500K shares) for new hires
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2024 Equity Incentive Plan to include pre-funded warrants in evergreen share calculation.
- Board adopted 2026 Inducement Plan reserving 500,000 shares of common stock for inducement grants to new employees without stockholder approval.
- Annual meeting results: re-elected directors Holtzman, Stewart, Young; ratified Ernst & Young as auditor for FY2026.
- Plan amendment and inducement plan both effective as of June 10, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736730/000162828026042846/0001628280-26-042846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736730/000162828026042846/camp-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-042846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer